FDA Panel Unclear on Osteoporosis Drug Labels
FDA Panel: Osteoporosis Drugs Need Better Labels Time Limits on the Drugs Are Suggested, but How Much Time Is Yet to Be Determined WebMD Medical News By Rita Rubin Reviewed...
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.